FRAGICAP
Research Group for the prevention, diagnosis and management of fragility and functional decline, both physical and cognitive in the elderly
Aging is a broad research area that encompasses all social and health aspects affecting the elderly, i.e., their overall health, diseases of the different physiological systems, use of health services, quality of life, etc. Aging research overlaps with other research areas, namely, cardiovascular, diabetes, mental health, cancer, lifestyles and health services. However, some aspects such as the study of frailty in the elderly, cognitive deterioration, multimorbidity, polypharmacy, home care and end-of-life care are very specific of this age group. Research in aging takes place within the framework of our aging society and its repercussions on the health and social systems, with emerging or increased incidence of new syndromes, the shift in family and care models and the new services on offer. The group includes GPs, primary care nurses, epidemiologists and health technicians. Two members of the team are PhDs and a third one is currently carrying out a PhD thesis with funding from the IDIAP and supervised by the group coordinator. The aim of the group is to carry out more PhD thesis. Fragicap has the support of the Aging Area of the IDIAP, and it currently collaborates with other research groups such as those of care in health, lifestyles, the Rediapp and also University College Cork and the Universidade do Porto.
The group participates in the following projects
|
PI: Franch Nadal, Josep. Aportacions de la genètica a la caracterització de una cohort de Medicina Personalitzada de Precisió en el moment del debut de la diabetis. Funding: Departament de Salut. Duration: 2022 - 2024 |
|
PI: Franch Nadal, Josep. Aportacions de la genètica a la caracterització de una cohort de Medicina Personalitzada de Precisió en el moment del debut de la diabetis. Funding: Departament de Salut. Duration: 2022 - 2024 |
|
PI: Salvador Gonzalez, Betlem. Ensayo clínico doble-ciego aleatorizado controlado con placebo para evaluar la eficacia en la sintomatología respiratoria leve-moderada de montelukast en pacientes con COVID persistente, PROYECTO E-SPERANZA COVID. Funding: Universitat Autònoma de Barcelona (UAB). Duration: 2021 - 2023 |
|
PI: Violán Fors, Concepció. Construcción y validación de un Score predictivo de riesgo de institucionalización, ingresos hospitalarios y mortalidad, en mayores de 65 años con multimorbilidad y fragilidad. Funding: Instituto de Salud Carlos III. Duration: 2020 - 2022 |
The group participates in the following publications
|
Carrasco-Ribelles LA, Roso-Llorach A, Cabrera-Bean M, Costa-Garrido A, Zabaleta-Del-Olmo E, Toran-Monserrat P, Orfila Pernas F, Violán C. Dynamics of multimorbidity and frailty, and their contribution to mortality, nursing home and home care need: A primary care cohort of 1 456 052 ageing people. EClinicalMedicine. 2022 Oct; 52:101610. doi:10.1016/j.eclinm.2022.101610. Epub 2022 Aug 11. pmc:PMC9399153. PMID:36034409. IF: . |
|
Díaz-Torné C, Pou MA, Rodríguez-Díez B, Pujol-Ribera E. Living with gout. Experiences, impact and challenges of the disease. Qualitative study through focus groups. Reumatol Clin (Engl Ed). 2022 Sep; doi:10.1016/j.reumae.2022.03.002. Epub 2022 Sep 01. PMID:36058814. IF: . |
|
Feijóo Rodríguez MV, Orfila Pernas F, Sánchez Callejas AV, Valero García C, Plaza Espuña I, Del Val García JL. [Frailty impact on COVID-19 disease in an older cohort from the city of Barcelona]. Aten Primaria. 2022 Sep; 54(9):102393. doi:10.1016/j.aprim.2022.102393. Epub 2022 May 23. Spanish. pmc:PMC9125044. PMID:35779366. IF: 1,137. |
|
Jacques-Aviñó C, Roel E, Medina-Perucha L, McGhie J, Pons-Vigués M, Pujol-Ribera E, Turiel I, Berenguera A. Are we leaving someone behind? A critical discourse analysis on the understanding of public participation among people with experiences of participatory research. PLoS ONE. 2022;17(9):e0273727--. PMID:36054140. IF: 3,240. |
|
Manchon-Walsh P, Aliste L, Borràs JM, Coll-Ortega C, Casacuberta J, Casanovas-Guitart C, Clèries M, Cruz S, Guarga À, Mompart A, Planella A, Pozuelo A, Ticó I, Vela E, Prades J. Socioeconomic Status and Distance to Reference Centers for Complex Cancer Diseases: A Source of Health Inequalities? A Population Cohort Study Based on Catalonia (Spain). Int J Environ Res Public Health. 2022 Jul; 19(14). doi:10.3390/ijerph19148814. Epub 2022 Jul 20. pmc:PMC9322195. PMID:35886665. IF: 4,614. |
|
Mata-Cases M, Mauricio D, Real J, Vlacho B, Romera-Liebana L, Molist-Brunet N, Cedenilla M, Franch-Nadal J. Potential Risk of Overtreatment in Patients with Type 2 Diabetes Aged 75 Years or Older: Data from a Population Database in Catalonia, Spain. J Clin Med. 2022 Aug; 11(17). doi:10.3390/jcm11175134. Epub 2022 Aug 31. pmc:PMC9457074. PMID:36079064. IF: . |
|
Middleton R, Poveda JL, Orfila Pernas F, Martinez Laguna D, Diez Perez A, Nogués X, Carbonell Abella C, Reyes C, Prieto-Alhambra D. Mortality, Falls, and Fracture Risk Are Positively Associated With Frailty: A SIDIAP Cohort Study of 890 000 Patients. J Gerontol A Biol Sci Med Sci. 2022 01; 77(1):148-154. doi:10.1093/gerona/glab102. pmc:PMC8751782. PMID:33885746. IF: 6,053. |
|
Orfila F, Carrasco-Ribelles LA, Abellana R, Roso-Llorach A, Cegri F, Reyes C, Violán C. Validation of an electronic frailty index with electronic health records: eFRAGICAP index. BMC Geriatr. 2022 May; 22(1):404. doi:10.1186/s12877-022-03090-8. Epub 2022 May 07. PMID:35525922. IF: . |
|
Pou MA, Orfila F, Pagonabarraga J, Ferrer-Moret S, Corominas H, Diaz-Torne C. Risk of Parkinson's disease in a gout Mediterranean population: A case-control study. Joint Bone Spine. 2022 Apr; doi:10.1016/j.jbspin.2022.105402. Epub 2022 Apr 30. PMID:35504516. IF: 4,929. |
|
Zamora JJ, del Val JL, Gost J, Lestón M, Orfila F, Llauger MA, Membres del Grup de treball. Característiques clíniques i fragilitat dels usuaris de l'atenció domiciliària a la ciutat de Barcelona. Butlletí de la CAMFIC. 2022;40(iss4):1-8. IF: . |
Indicators
|
Indicator |
2022 |
|---|---|
|
Researchers with PhD |
3 |
|
Total number of projects in which group members have participated |
6 |
|
Total number of projects in which the PI of the project has belonged to the group |
|
|
Total Funding |
228.424,64€ |
|
Scientific publications in indexed journals |
5 |
|
Total Impact factor |
19,97 |
|
Nº of articles in Q1 journals |
2 |
|
Q1 IF |
10,667 |
|
Nº of articles in Q2 journals |
2 |
|
Q2 IF |
8,169 |
